EXECUTIVE INTERVIEWS

Purdue Pharma — From Private Franchise To Open Business

In some ways, it is easy to see Purdue and its singular pain-med focus as a model preserved from the time I began covering the industry in the mid-1980s. The typical pharma company back then had a franchise, sometimes a virtual monopoly, in a given area, and the industry overall was more collegial than competitive.

More From Executive Interviews

THE CURRENT ISSUE

  • Patent Reform Pits Life Sciences Against High-Tech And Hedge Funds
    Patent Reform Pits Life Sciences Against High-Tech And Hedge Funds

    Shivers went down the spine of many biotech executives when Kyle Bass’ hedge fund, Hayman Capital Management, announced it would exploit a relatively new provision in patent law that allows any person (not just a generic competitor or related party) to challenge and invalidate patents at the U.S. Patent & Trademark Office (USPTO).

  • Remote Clinical Trials: A Goal Just Over The Horizon
    Remote Clinical Trials: A Goal Just Over The Horizon

    People don’t think twice to pay bills on a smartphone, share experiences on social media, and even monitor sleep habits on wearable activity trackers. But when it comes to participating in a study to test a new therapy or medical device, we might as well be standing in line at the bank to deposit a paper check.

  • Building A Successful CMO/CRO Partnership: What’s Important To Emerging Pharma And Emerging Biotech?
    Building A Successful CMO/CRO Partnership: What’s Important To Emerging Pharma And Emerging Biotech?

    More than ever, pharmaceutical and biotechnology companies are considering CROs and CMOs as partners in collaboration to achieve long-term development goals.

  • Innovation In Clinical Trials: What Can We Expect In 2015 And Beyond?
    Innovation In Clinical Trials: What Can We Expect In 2015 And Beyond?

    Innovation is a critical topic in the pharmaceutical industry. It is what will help the industry keep on top of quality issues, develop new products, speed needed medicines to patients, and bring down the cost of the entire process. However, identifying where it can best happen and then making the vision a reality is also one of the toughest challenges that sponsors face.

  • Japan’s Take On Regenerative Medicine: Early Commercialization, Early Reimbursement
    Japan’s Take On Regenerative Medicine: Early Commercialization, Early Reimbursement

    New regulations accelerating the approval of regenerative therapeutics in Japan took effect Nov. 25, 2014, propelling that nation onto the radar screens of life sciences companies around the world. The chief benefit of these new rules is that they enable companies to receive conditional marketing approval and generate revenue from regenerative products while trials are being conducted.

  • Advice From A Serial Pharmaceutical Entrepreneur
    Advice From A Serial Pharmaceutical Entrepreneur

    Twenty-two years after graduating college, Michael Jaharis purchased his first pharmaceutical company. That was in 1972. Four decades later he had amassed a career — and a fortune — in the pharmaceutical industry highlighted by the sales of three companies: Key Pharmaceuticals, Kos Pharmaceuticals, and Pearl Therapeutics.

  • Small Pharma And Large CROs: Considerations For Partnering
    Small Pharma And Large CROs: Considerations For Partnering

    When it comes to selecting a CRO, pharma companies have a lot of decisions to make. Do you go with a CRO that has experience and expertise in your study? How should you rank their proficiency in critical areas such as regulatory, quality, and timeliness? Do you go with a CRO you have familiarity with or try something new?

More Magazine Articles....

 UPCOMING TRAINING COURSES

Building An Effective GMP Training System: A Risk-Based Approach

May 27, 2015
1pm-2:30pm EDT, Online Training

Introduction to Biostatistics: Collecting and Summarizing Data

May 28, 2015
1pm-3pm EDT, Online Training

FDA GMP Inspections – Proven Preparation & Survival Techniques

June 2, 2015
1pm-2:30pm EDT, Online Training

Surviving a FDA GCP Inspection – Preparation Techniques for Success

June 11, 2015
1pm-2:30pm EDT, Online Training
More Upcoming Courses

VIEW THE DIGITAL EDITION

May 2015

 

2015 CRO LEADERSHIP AWARDS - SUPPLEMENT

2015 CRO Leadership Awards

 

 UPCOMING EVENTS

Building An Effective GMP Training System: A Risk-Based Approach

May 27, 2015
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Introduction to Biostatistics: Collecting and Summarizing Data

May 28, 2015
1pm-3pm EDT, Online Training
Price:  $349 - Introductory Rate

Pediatric Clinical Trials: Special Considerations and Requirements

June 1, 2015
2pm-3:30pm EDT, Online Training
Price:  $299 - Introductory Rate

FDA GMP Inspections – Proven Preparation & Survival Techniques

June 2, 2015
1pm-2:30pm EDT, Online Training

Cost-Efficient/Cost-Effective Validation Protocols

June 3, 2015
1pm-2:30pm EDT, Online Training
Price:  $299
See All Events